To evaluate the effects of BRCA2 ASO and olaparib on population dynamics and resistance to treatment over time, we devised a co-culture model of SKOV-3 ovarian cancer cells stably expressing either shRNA targeting BRCA2 or control shRNA. The gene discussed is BRCA2; the disease is ovarian cancer.